Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
37,118,700
-
Share change
-
-477,603
-
Total reported value
-
$32,662,073
-
Put/Call ratio
-
18%
-
Price per share
-
$0.88
-
Number of holders
-
66
-
Value change
-
-$641,512
-
Number of buys
-
25
-
Number of sells
-
23
Institutional Holders of LEAP THERAPEUTICS INC - COM (LPTX) as of Q3 2022
As of 30 Sep 2022,
LEAP THERAPEUTICS INC - COM (LPTX) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,118,700 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Artal Group S.A., Rock Springs Capital Management LP, VANGUARD GROUP INC, M28 Capital Management LP, 683 Capital Management, LLC, PLATINUM INVESTMENT MANAGEMENT LTD, TANG CAPITAL MANAGEMENT LLC, BlackRock Inc., and Key Client Fiduciary Advisors, LLC.
This page lists
66
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.